Humana Inc
NYSE: HUM
$280.06
-$2.38 (-0.8%)
Closing Price on November 12, 2024
HUM Articles
ThinkstockHumana Inc. (NYSE: HUM) reported its second-quarter financial results Wednesday before the markets opened. The company had $1.67 in earnings per share (EPS) on $13.73 billion in revenue...
Published:
Last Updated:
Argus thinks the sell-off in Aetna stock following the Humana merger announcement on July 3 presents a buying opportunity.
Published:
Over the long weekend, the first move toward an acquisition was made in the health insurance industry.
Published:
Monday's top analyst upgrades, downgrades and initiations include Epizyme, Goldcorp, GoPro, Intuitive Surgical and VMware.
Published:
The U.S. Department of Justice is now said to be set to give a very close review of any of the proposed mergers of the top health insurance players in America.
Published:
Merger talks within the health insurance sector are reaching a critical point, and it appears that there will be some major moves in the very near future.
Published:
24/7 Wall St. cannot help but wonder if it is possible that one of these top health insurance companies could be left without a merger partner.
Published:
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, Cisco Systems, Frontier Communications, Marvell Technology, Yingli Green Energy and AT&T.
Published:
Monday's top analyst upgrades, downgrades and initiations Include Ambev, CTI BioPharma, Duke, Humana, Occidental Petroleum and Yelp.
Published:
Wednesday's top analyst upgrades, downgrades and initiations include American Eagle Outfitters, AOL, Boeing, Lululemon Athletica, Microsoft, ResMed and Vivint Solar.
Published:
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
Published:
Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour and El Pollo Loco.
Published:
Humana reported disappointing third-quarter 2014 results before markets opened Friday morning.
Published:
Last Updated:
A new research report from the analysts at Stifel notes that the managed care organizations (MCOs) have posted solid results and raised earnings estimates, and they have been sold off.
Published:
ThinkstockBinary events are often the key element in moving a biotech or health care stock higher. Negative binary results or actions often can move shares drastically lower. We scan our 24/7 Wall...
Published: